Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF OBESITY
Volume 40, Issue 8, Pages 1310-1319
Publisher
Springer Nature
Online
2016-03-23
DOI
10.1038/ijo.2016.52
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing Sleep Duration for a Healthier (and Less Obese?) Population Tomorrow
- (2017) Terry Young SLEEP
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians
- (2015) Amir Qaseem et al. ANNALS OF INTERNAL MEDICINE
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- The impact of weight reduction in the prevention of the progression of obstructive sleep apnea: an explanatory analysis of a 5-year observational follow-up trial
- (2014) Henri Tuomilehto et al. SLEEP MEDICINE
- Increased Prevalence of Sleep-Disordered Breathing in Adults
- (2013) P. E. Peppard et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
- (2013) J van Can et al. INTERNATIONAL JOURNAL OF OBESITY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Respiratory effort-related arousals contribute to sympathetic modulation of heart rate variability
- (2013) Subani Chandra et al. Sleep and Breathing
- Weight Reduction and Increased Physical Activity to Prevent the Progression of Obstructive Sleep Apnea: A 4-Year Observational Postintervention Follow-up of a Randomized Clinical Trial
- (2013) Henri Tuomilehto et al. JAMA Internal Medicine
- Surgical vs Conventional Therapy for Weight Loss Treatment of Obstructive Sleep Apnea
- (2012) John B. Dixon et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults
- (2012) David H. Winslow et al. SLEEP
- Obesity and obstructive sleep apnea – Clinical significance of weight loss
- (2012) Henri Tuomilehto et al. SLEEP MEDICINE REVIEWS
- Blood Pressure: The Lower, the Better: The con side
- (2011) E. Grossman DIABETES CARE
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial
- (2010) Michaela Diamant et al. LANCET
- A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesThe Sleep AHEAD StudyEffect of Weight Loss on Obstructive Sleep Apnea
- (2009) Gary D. Foster ARCHIVES OF INTERNAL MEDICINE
- Standards of Medical Care in Diabetes--2010
- (2009) DIABETES CARE
- The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Lifestyle Intervention with Weight Reduction
- (2008) Henri P. I. Tuomilehto et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sleep Apnea and Cardiovascular Disease
- (2008) Virend K. Somers et al. CIRCULATION
- Abdominal Fat and Sleep Apnea: The chicken or the egg?
- (2008) G. Pillar et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started